Michael Cloonan - President & CEO, Director at Sionna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SION on Nasdaq
All Insider Reports
All Insider Reports

Michael Cloonan - trading volume in the past year for Sionna Therapeutics, Inc.

Holdings reported by Michael Cloonan for Sionna Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 547K $20.4M $37.31 Oct 21, 2025 Direct
Stock Option (Right to Buy) 450K Feb 6, 2025 Direct Common Stock
Non-Qualified Stock Option (right to buy) 53.1K Oct 21, 2025 Direct Common Stock

Transactions reported by Michael Cloonan for Sionna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.